Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0EK7H
|
|||
| Former ID |
DNC007193
|
|||
| Drug Name |
4,7-dichloro-1H-indole-2,3-dione
|
|||
| Synonyms |
4,7-Dichloroisatin; 18711-13-2; 4,7-dichloroindoline-2,3-dione; 4,7-dichloro-1H-indole-2,3-dione; 4,7-dichloro isatin; 4,7-dichloro-isatin; 4,7-dichloro-2,3-dihydro-1H-indole-2,3-dione; 1H-Indole-2,3-dione, 4,7-dichloro-; 4,7-dichloroisatin;; 4,7-dichloroisatine;; AC1MC1Y2; Isatin-based compound, 51; ACMC-1C3I3; 4,7-Dichloroisatin, 97%; KSC494I6J; SCHEMBL281619; CHEMBL223039; 4,7-Dichloroindole-2,3-dione; CTK3J4464; BDBM22831; DTXSID90370507; 4,7-Dichloro-2,3-indolinedione; MolPort-001-766-630; 4,7-Dichloroindole-2,3-dione;
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C8H3Cl2NO2
|
|||
| Canonical SMILES |
C1=CC(=C2C(=C1Cl)C(=O)C(=O)N2)Cl
|
|||
| InChI |
1S/C8H3Cl2NO2/c9-3-1-2-4(10)6-5(3)7(12)8(13)11-6/h1-2H,(H,11,12,13)
|
|||
| InChIKey |
NUXYYWOWNFEMNH-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 18711-13-2
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Liver carboxylesterase (CES1) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Drug metabolism - other enzymes | |||
| Metabolic pathways | ||||
| Pathway Interaction Database | E2F transcription factor network | |||
| WikiPathways | NRF2 pathway | |||
| Nuclear Receptors Meta-Pathway | ||||
| Heroin metabolism | ||||
| Irinotecan Pathway | ||||
| Fluoropyrimidine Activity | ||||
| Phase I biotransformations, non P450 | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Selective inhibition of carboxylesterases by isatins, indole-2,3-diones. J Med Chem. 2007 Apr 19;50(8):1876-85. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.